Service Member Receives Vaccine NO REACTION LOCAL REACTION (Occur more often in women than men) Document. Educate. Continue to screen for exclusion criteria.

Slides:

Advertisements

Similar presentations

AEs, SAEs, and EAEs – An Overview

Advertisements

ADVERSE EVENT REPORTING

Acute Angioedema Gabriele de Vos, M.D., M.Sc. Division of Allergy and Immunology Jacobi Medical Center Albert Einstein College of Medicine.

Managing Side Effects of TKIs

Introduction Director’ s Welcom e INFLUENZA Department of Defense Seasonal Influenza Vaccination Program Leaders Briefing UNCLASSIFIED.

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). Do not use ibuprofen just before or after heart bypass surgery (coronary artery bypass graft,

Unit 8: Complications and Special Situations Botswana National Tuberculosis Programme Manual Training for Medical Officers.

A Red Flags: 1. Progressively declining level of consciousness 2. Progressive declining neurological exam 3. Pupillary asymmetry 4. Seizures 5. Repeated.

Food Allergies and Allergic Reactions When and How to Use an Epi-Pen.

 2001 DEY B /01. Definition of Anaphylaxis Systemic allergic reaction –Affects body as a whole –Multiple organ systems may be involved Onset.

Management of Smallpox Vaccine Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention February 2003.

Migraines Mark Green, MD Clinical Professor Department of Neurology Columbia University New York, NY.

Fainting and Anaphylaxis Needlestick Injuries Bryna Warshawsky, MDCM, FRCPC Associate Medical Officer of Health Middlesex-London Health Unit.

MILD TRAUMATIC BRAIN INJURY IN PATIENTS WITH VASCULAR DEMENTIA Yuri Alekseenko Department of Neurology and Neurosurgery Vitebsk Medical University Vitebsk,

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.

Natalie Garcia Anatomy&Physiology 4 th Period. History Of The Disease  First described in 1860 by Ferdinand von Hebra as a severe, self-limiting disorder.

Erythema By Dr. Mohamad Nasr Lecturer Of Dermatology & Venereology.

Headache and Internal Analgesics. Headaches Most common pain complaint 40% of US population have recurrent HA Classifications:  Primary HA: 90% of HAs,

Smallpox Vaccine Contraindications and Screening Department of Health and Human Services Centers for Disease Control and Prevention December 2002 Note:

Head Injury Psychological Services San Antonio Police Department Head Injury Psychological Services San Antonio Police Department.

Understanding Drugs and Medicines

Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.

“My migraine always comes back” Presented by: Julio Pascual Neuroscience Area, Service of Neurology, University Hospital Central de Asturias and Ineuropa,

Rapivab™ - peramivir injection

Dr. Steven I. Dworkin Drugs That Affect the Musculoskeletal System.

Limmer et al., Emergency Care, 10 th Edition © 2005 by Pearson Education, Inc. Upper Saddle River, NJ CHAPTER 20 Allergic Reactions.

1 Hepatitis A and B Vaccination and the New York State Adult Hepatitis Vaccination Program Elizabeth Rausch-Phung, MD MPH Medical Director, NYSDOH Bureau.

Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 6 Nonopiod (Nonnarcotic) Analgesics.

Anaphylaxis in Schools Recognizing Anaphylaxis Epinephrine Auto-injector Administration Betsy Stoffers RN 2014.

1 08 Feb 07 Anthrax Vaccine Immunization Program Individual Briefing.

The Growing Knee OA Population

Azurin, Edelyn Babaran, Krystel. Mode of Action inhibit the fungal cytochrome P A dependent enzyme 14-alpha demethylase inhibit the fungal cytochrome.

ADVERSE EFFECTS OF DRUGS Phase II May Adverse Drug Reaction An adverse reaction to a drug is a harmful or unintended response. ADRs are claimed.

Oxycontin This Lesson Plan Produced By Your Drug Demand Reduction Program 1.

1 DoD Smallpox Vaccination Program Policy – Training – Standards – Communication – Safety Assurance – Safety Assessment Science – Quality – Confidence.

Pharmacology 3 Safety and Effectiveness in Medicines Administration Applying the Evidence Base.

H1N1 Update Marty White October 12, H1N1 Information  Pandemic declared by World Health Organization in June 2009  The symptoms include fever,

Approved: 9 Jun DoD Leader’s Briefing: Force Health Protection Against Anthrax.

Severe Allergic Reaction (Anaphylactic Shock) 过敏性休克 Fang Hong 方红 1st Affiliated Hospital, Zhejiang University.

Assisting Students With Severe Allergies: Epinephrine Auto-injector Training Instructor’s Name: Myra Pickard, RN BSN, NCSN.

Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 17 Nonopioid Analgesics: Salicylates and Nonsalicylates.

Allergy in 10 minutes DETECTIVE WORK Presenting episode Previous episodes Consistent trigger or pattern to episodes Contacts/Foods in previous 4 hours.

Figure 1 - Frequency Distribution of All VAERS LYMErix® Reports by Age at Onset of Adverse Event Age not available for 171 (16%) reports Interpretation.

Seminar 4. Unit 4 Inpatient coding guidelines Principal diagnosis: “that condition established after study to be chiefly responsible for occasioning the.

Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention December 2002.

DRUG INTERACTIONS. –Adverse drug effects –Hypersensitivity –Anaphylactic reactions.

Caverta An Oral Remedy For Better Lovemaking. Introduction Cavetra is an oral therapeutic medicament characterized to treat male impotency. Its Sildenafil.

Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.

* QUINIDINE  Quinidine has pronounced cardiac anti muscarinic effects. It is absorbed orally. It undergoes extensive metabolism by the hepatic cytochrome.

Walter Reed National Vaccine Healthcare Center (VHC) Network Vaccine Adverse Events Diagnosis, Evaluation, Management & Reporting Guidelines for Quality.

Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 84 Allergic, Immune, and Autoimmune Disorders.

CATEGORY: IMMUNE DYSFUNCTION Anaphylaxis Tariq El-Shanawany, University Hospital of Wales, UK Anaphylaxis is a severe, life-threatening, generalised or.

COMPARISON OF ADVERSE EFFECT PROFILES OF PAIN REGIMENS WITH AND WITHOUT INTRAVENOUS ACETAMINOPHEN IN TOTAL HIP AND KNEE ARTHROPLASTY PATIENTS Alyssa J.

TM Influenza Vaccine Safety in Children: Data from VAERS John Iskander MD MPH Gina Mootrey DO MPH Penina Haber MPH Roseanne English-Bullard BS.

Vaccination POD Just-in-Time Training. A list of Vaccinators and Vaccinator Assistants at each station will be maintained by the Administrative Representative.

iMAP Guideline for Primary Care and ‘First Contact’ Clinicians

Managing Food Allergies

Foundations of Interprofessional Collaboration (FIPC): An Introduction to TeamSTEPPS® LEVEL 3 Overview of Clinical Management of Anaphylaxis for Respiratory.

Drug Therapy of Gout 1.

Question 4 – Redback spider

Safety Reporting Nichol McBee, MPH, CCRP.

Maternal Toxicity Management

CHAPTER 20 Allergic Reactions.

CD-JEV AEFI monitoring

Managing Seizures in the Classroom

Smallpox Vaccine Contraindications and Screening

Anaphylaxis A Life Threatening Allergy

Dexamethasone 4mg/mL inj Susan Bradley, PharmD/RPh

Presentation transcript:

Service Member Receives Vaccine NO REACTION LOCAL REACTION (Occur more often in women than men) Document. Educate. Continue to screen for exclusion criteria (e.g. steroid therapy, pregnancy). Continue series. MILD LOCAL REACTION Redness < 50 mm diameter, pain, swelling lump, itching. (LR1, LR2, LR3) Document. Educate. Offer topical corticosteroids, antihistamines, analgesics. 1,2 Continue series. Exercise as tolerated after next dose. MODERATE LOCAL REACTION Redness mm diameter, pain, swelling, lump, itching, numbness, tingling, (LR1, LR4, LR7) * Document. Educate. Treat within first 24 hrs with topical corticosteroids, antihistamines, +/- NSAIDS prn for pain. Consider pretreatment for next dose. 1,2,3,7 Continue series. Exercise as tolerated after next dose. LARGE LOCAL REACTION, + COMPLICATIONS Redness > 120 mm, pain, swelling to or below elbow, local rash (LR1, LR5, LR6, LR8) * Document. Educate. Take photo, if possible. Consider consultation with next level of care. Treat symptoms: Corticosteroids, antihistamines, and/or NSAIDs as needed for pain. Pretreat before next dose. 1,2,3,7 Consider temporary exemption, pending consult. Decreased reaction: Continue Worsening reaction: Reevaluate. Possible temp. exemption. Pretreatment schedule. Guidelines for Nov 1999 through Jun Version: This document provides general guidance, to adapt to individual clinical cases. Use with companion tables. Revisions to this document will be disseminated via medical command channels and posted on the AVIP website, The probability of events on this chart is not uniform: some are quite common and some are rare. See cover sheet for details. Acknowledgement: This chart originated with the Allergy/Immunology Department, Walter Reed Army Medical Center. ALGORITHM FOR ADVERSE EVENTS AFTER VACCINATION Submit Form VAERS-1 as warranted. Must be submitted for hospitalization, loss of duty > 24 h, or suspected vial contamination. Other events may also be reported. Forms available at * If in yellow or red zone, avoid simultaneous administration with other vaccines.

OTHER SYSTEMIC DISEASE Presenting or worsening in temporal association with vaccine SYSTEMIC REACTION (Occur more often in women than men) Myalgias, arthralgias, “flu”-like symptoms temperature o F, fatigue, nausea, vomiting, headaches lasting h, syncope or near syncope, tinnitus, dizziness, focal rash, prolonged fatigue, anxiety response. Occur more often in women than men. (SE1, SE2, SE4, SE5, SE6, SE7, SE8, SE15, SE16) * Temperature >100.5  F or systemic symptoms >72 h OR temperature >102  F, recurrent headaches, generalized rashes (SE3, SE4, SE9) * ANAPHYLAXIS, Systemic allergic reaction, Serum sickness (SE11, SE12) * NEUROLOGIC DISEASE Peripheral neuropathy, Encephalopathy Guillain-Barré, Focal neurologic disease (SE13, SE14) * GENERALIZED SKIN REACTION Toxic epidermal necrolysis, Erythema multiforme, StevensJohnson syndrome, Exfoliative dermatitis (SE10) * Document. Educate. Consult as needed. Consider continuing with pre/post-treatment NSAID. Headache: acetaminophen mg q 4-6 h, ibuprofen, et cetera. 1,2,4 Document. Educate. Treat with antihistamines, corticosteroids. 1,2,5 Consider temp. exemption, pending consult. Treat. Document. Educate. Give temporary exemption, pending prompt consult. Treat. Document. Educate. Take photo, if possible. Give temporary exemption, pending immediate consult. Treat. Document. Educate. Consider temporary exemption, pending consult. 6 Tolerates next dose: continue. For recurrent or worsening symptoms: Consider temporary exemption, pending consult. ALGORITHM FOR ADVERSE EVENTS AFTER VACCINATION Service Member Receives Vaccine Treat acute event. Document. Educate. Give temporary exemption, pending allergy consult. 4 Discuss value of desensitization. Guidelines for Nov 1999 through Jun Version: This document provides general guidance, to adapt to individual clinical cases. Use with companion tables. Revisions to this document will be disseminated via medical command channels and posted on the AVIP website, The probability of events on this chart is not uniform: some are quite common and some are rare. See cover sheet for details. Acknowledgement: This chart originated with the Allergy/Immunology Department, Walter Reed Army Medical Center. Submit Form VAERS-1 as warranted. Must be submitted for hospitalization, loss of duty > 24 h, or suspected vial contamination. Other events may also be reported. Forms available at * If in yellow or red zone, avoid simultaneous administration with other vaccines.